EP2734575A1 - Whey protein coated films - Google Patents
Whey protein coated filmsInfo
- Publication number
- EP2734575A1 EP2734575A1 EP11764857.6A EP11764857A EP2734575A1 EP 2734575 A1 EP2734575 A1 EP 2734575A1 EP 11764857 A EP11764857 A EP 11764857A EP 2734575 A1 EP2734575 A1 EP 2734575A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- whey
- protein
- whey protein
- film
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010046377 Whey Proteins Proteins 0.000 title claims abstract description 145
- 102000007544 Whey Proteins Human genes 0.000 title claims abstract description 127
- 235000021119 whey protein Nutrition 0.000 title claims abstract description 118
- 239000000758 substrate Substances 0.000 claims abstract description 91
- 238000000034 method Methods 0.000 claims abstract description 72
- 230000008569 process Effects 0.000 claims abstract description 50
- 238000004806 packaging method and process Methods 0.000 claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 16
- 229920006280 packaging film Polymers 0.000 claims abstract description 7
- 239000012785 packaging film Substances 0.000 claims abstract description 7
- 238000000576 coating method Methods 0.000 claims description 77
- 239000011248 coating agent Substances 0.000 claims description 62
- 238000001035 drying Methods 0.000 claims description 41
- 239000004014 plasticizer Substances 0.000 claims description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 28
- 239000008199 coating composition Substances 0.000 claims description 16
- 230000004048 modification Effects 0.000 claims description 15
- 238000012986 modification Methods 0.000 claims description 15
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 12
- 239000000600 sorbitol Substances 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 230000021736 acetylation Effects 0.000 claims description 9
- 238000006640 acetylation reaction Methods 0.000 claims description 9
- 230000035322 succinylation Effects 0.000 claims description 9
- 238000010613 succinylation reaction Methods 0.000 claims description 9
- 238000003851 corona treatment Methods 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 7
- 239000006096 absorbing agent Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 239000004971 Cross linker Substances 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 239000002216 antistatic agent Substances 0.000 claims description 3
- 239000003139 biocide Substances 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 238000009832 plasma treatment Methods 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 235000013772 propylene glycol Nutrition 0.000 claims description 3
- 230000009144 enzymatic modification Effects 0.000 claims 2
- 229920006281 multilayer packaging film Polymers 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 description 73
- 108090000623 proteins and genes Proteins 0.000 description 73
- 235000018102 proteins Nutrition 0.000 description 72
- 238000004925 denaturation Methods 0.000 description 46
- 230000036425 denaturation Effects 0.000 description 46
- 239000010410 layer Substances 0.000 description 43
- 239000000243 solution Substances 0.000 description 42
- 239000000463 material Substances 0.000 description 33
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 29
- 239000001301 oxygen Substances 0.000 description 29
- 229910052760 oxygen Inorganic materials 0.000 description 29
- 230000004888 barrier function Effects 0.000 description 28
- 239000005862 Whey Substances 0.000 description 27
- 239000000047 product Substances 0.000 description 19
- 238000010438 heat treatment Methods 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 238000009472 formulation Methods 0.000 description 16
- 229920000139 polyethylene terephthalate Polymers 0.000 description 11
- 239000012460 protein solution Substances 0.000 description 10
- 230000002776 aggregation Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000005022 packaging material Substances 0.000 description 8
- 239000004698 Polyethylene Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 7
- 239000001257 hydrogen Chemical group 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 229920000573 polyethylene Polymers 0.000 description 7
- 238000004220 aggregation Methods 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 239000012159 carrier gas Substances 0.000 description 6
- 230000007071 enzymatic hydrolysis Effects 0.000 description 6
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 125000003396 thiol group Chemical group [H]S* 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 5
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229920001684 low density polyethylene Polymers 0.000 description 5
- 239000004702 low-density polyethylene Substances 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- -1 polypropylene Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000002203 pretreatment Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000007385 chemical modification Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000003475 lamination Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000021485 packed food Nutrition 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 230000009145 protein modification Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000000113 differential scanning calorimetry Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 238000009928 pasteurization Methods 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 238000007585 pull-off test Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000002344 surface layer Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000000930 thermomechanical effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229920008790 Amorphous Polyethylene terephthalate Polymers 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 238000007756 gravure coating Methods 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000011020 pilot scale process Methods 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 239000005033 polyvinylidene chloride Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003856 thermoforming Methods 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000013006 addition curing Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007754 air knife coating Methods 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003000 extruded plastic Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000005003 food packaging material Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 102000034238 globular proteins Human genes 0.000 description 1
- 108091005896 globular proteins Proteins 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000012994 industrial processing Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000002651 laminated plastic film Substances 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 238000007760 metering rod coating Methods 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000006432 protein unfolding Effects 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000007763 reverse roll coating Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007761 roller coating Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical group OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000013060 ultrafiltration and diafiltration Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/048—Forming gas barrier coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D3/00—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
- B05D3/007—After-treatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D3/00—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
- B05D3/14—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials by electrical means
- B05D3/141—Plasma treatment
- B05D3/142—Pretreatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D65/00—Wrappers or flexible covers; Packaging materials of special type or form
- B65D65/38—Packaging materials of special type or form
- B65D65/42—Applications of coated or impregnated materials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/042—Coating with two or more layers, where at least one layer of a composition contains a polymer binder
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/043—Improving the adhesiveness of the coatings per se, e.g. forming primers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/046—Forming abrasion-resistant coatings; Forming surface-hardening coatings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31725—Of polyamide
- Y10T428/31768—Natural source-type polyamide [e.g., casein, gelatin, etc.]
Definitions
- the present invention relates to the plastic field, particularly to the use of whey-protein films in multilayer films for packaging applications.
- Paper, board and currently available polymers and/or biopolymer films are mostly used in combination with barrier materials derived from oil based plastics or aluminum to enhance their low barrier properties.
- barrier materials derived from oil based plastics or aluminum to enhance their low barrier properties.
- current research efforts are focused on the development of sustainable coating while still maintaining the functional properties of the resulting packaging materials.
- high demands are put on packaging material in order to preserve the quality of the packed good throughout its lifecycle.
- the requirements for a packaging material are specific to the type of good to be packed. Materials need to fulfill different barrier to light, moisture, water vapour and gases. Appropriate levels of oxygen, and carbon dioxide, required packing atmosphere, respiration rate and thus optimally preserve the packed food, avoid colour or taste deviation, oxidation of grease, formation of microorganisms, damaging of nutrients, etc. have to be taken into account.
- Whey is a by-product of cheese manufacturing that contains approximately 7% dry matter. In general the dry matter includes 13% proteins, 75% lactose, 8% minerals, about 3% organic acids and less than 1 % fat. Two main kind of whey exist:
- Sweet whey originates from rennet- coagulated cheese production such as Cheddar.
- Sour whey with a pH approximately 4.6, results from the manufacture of acid-coagulated cheese.
- the technical definition for whey protein is "those that remain in the milk serum after coagulation of the caseins at pH 4.6 and temperature 20 Q C”.
- Whey proteins are a mixture of proteins with numerous and diverse functional properties and therefore have many potential uses in food applications.
- the major whey proteins are ⁇ -Lactoglobulin ( ⁇ -Lg) and a-Lactalbumin (a-La). They represent approximately 70 % of the total whey proteins and are responsible for the hydration, gelling and surface-active properties of the whey protein ingredients.
- the other major proteins are Bovine Serum Albumin (BSA) and Immunoglobulin (Ig).
- Whey proteins are soluble over a wide range of pH. However, various combinations of pH, temperature, and mineral composition induce selective denaturation, aggregation, and precipitation of whey proteins. In general, whey proteins are heat-labile proteins. Heat decreases their stability in the following order: a-La> -Lg>BSA>lg. Thermal denaturation and heat gelation of whey proteins are important functional characteristics in numerous products. The stability of the tertiary structure of whey proteins is determined by various non-covalent interactions and by the disulfide bonds, which are formed by two cysteine residues.
- ⁇ -Lg has two internal disulfide bonds and one free thiol group, while a-La has eight cysteine groups that are all involved in internal disulfide bonds.
- the first step during heat treatment involves a preliminary change in the conformational structure of protein, the denaturation step.
- the second and distinctly different step involves the process of aggregation, and this may be followed by coagulation or gelation.
- Denaturation has been defined as a major change of the very specific native protein structure, without alteration of the amino acid sequence. Thus changes are restricted to those occurring in secondary or higher-order structure.
- Protein-protein interactions determine the characteristics of the film. Film-forming ability may be influenced by amino acid composition, distribution, and polarity, conditions necessary for ionic crosslinks between amino and carboxyl groups, hydrogen bonding groups, and intramolecular and intermolecular disulfide bonds.
- Native and heat-denatured films differ in physical structures. Native whey proteins are globular proteins with most hydrophobic and sulfhydryl groups turned to the interior of the molecule. Heat denaturation of the whey proteins induces protein unfolding and exposure of internal sulfhydryl groups, promoting intermolecular disulfide bond formation. Such differences influence the molecular structure of the final film.
- heat denatured whey-protein films are made of cross-linked protein strands, whereas native whey-protein films have a more random structure in which cohesion is mainly due to hydrogen bonding. These different structures results in different permeability properties of the resulting films.
- ⁇ -Lg is the dominant whey protein, it tends to control the thermal behaviour of the total whey protein system.
- This protein has already been subject to many studies and it is generally accepted that thiol/disulphide exchange reactions, leading to the formation of intermolecular disulphide bonds, play a significant role in the heat-induced denaturation and aggregation of ⁇ -Lg. Heat-induced denaturation and aggregation of whey proteins may result in the formation of a gel, depending on experimental conditions such as protein concentration, pH, presence and concentration of salts and heating temperature
- Oxygen-barrier layers in food packaging materials typically consist of expensive synthetic barrier polymers including ethylene vinyl alcohol (EVOH) copolymers, polyvinylidene chloride (PVDC), polyethylene terepthalate (PET), and polyamide-6 (nylon), which are commonly used in the form of coextruded or laminated films and coatings.
- EVOH ethylene vinyl alcohol
- PVDC polyvinylidene chloride
- PET polyethylene terepthalate
- nylon-6 polyamide-6
- Water vapour and oxygen are two of the main permeants studied in packaging applications, because they may transfer from the internal or external environment through the polymer package wall, resulting in a continuous change in product quality and shelf-life.
- the oxygen barrier is quantified by the oxygen permeability coefficients (OPC) which indicate the amount of oxygen that permeates per unit of area and time in a packaging material.
- OPC oxygen permeability coefficients
- the films should be usable in multilayer constructions with standard thermoplastic materials during the production process, and also enable a good adhesion on these common substrates. Additionally, the films must show good barrier properties, as well as adhesion, mechanical properties, permeability, good processability (deformability and deformation speed rate).
- the present invention relates to the development of barrier layers or film based on whey protein to be used in multilayer-films principally for food packaging. Although, taking into account the properties obtained for the material, its use is considered also in other application such as pharmaceutical and cosmetics packaging.
- the inventors have found that it is possible to carry out an efficient industrial process for the manufacture of a whey-protein coated substrate film for packaging by using native whey protein during the coating step, whereas denaturation of the protein occurs during the drying step.
- Native whey protein formulations can be applied with higher solid contents compared to fully denatured whey protein formulations, leading to solutions which can easily be used for the coating process in all classic process types (i.e., gravure, spraying, comma, curtain and multi-roller applications).
- the simultaneous denaturation and drying (curing and crosslinking) of the coating leads to avoidance of the upstream denaturation process and thereby to a considerable saving of process energy.
- the result is an additional increase in efficiency because less water has to be evaporated during the drying process.
- the present invention provides an improved industrial process for the preparation of whey protein-based coated substrate films for packaging, which is cost-effective, consumes less water and saves energy and can be performed using standard coating processes.
- a first aspect of the invention relates to a process of preparing a whey-protein coated substrate film for packaging, wherein such manufacturing process comprises the following steps:
- whey protein component has at least 40% of its proteins in its native state, which is selected from the group consisting of a water solution of a whey protein isolate, a whey protein concentrate, and a mixture thereof;
- step b) applying directly the coating composition of step a) onto a substrate film in order to obtain a coated substrate film wherein the coating has at least 40% of the whey protein in its native state;
- a second aspect of the invention relates to a whey-protein coated substrate obtainable by the process according to the invention.
- a packaging film comprising the whey protein coated substrate as defined herein.
- Another aspect of the invention relates to the use of whey protein with a nativity degree of at least 40 % for preparing the whey-protein coated substrate as defined in the present invention.
- another aspect of the invention relates to a food, pharmaceutical or cosmetic product packaged in a packaging film as defined herein.
- the whey-protein layer is designed to be either an intermediate layer within a composite (multilayer structure) or a surface layer, but in any case it needs to be combined with the structural layer (substrate).
- both the intermediate layer within a composite (multilayer structure) and the surface layer are barrier layers.
- barrier layers To ensure the retention of modified, vacuum or normal atmosphere during the lifetime of the packaging and protect the packaged product (food stuff, pharmaceutical ingredient, etc) from the exterior, many different substrates are often combined into a structure with several layers, each layer having its own function. Combination of layers is not only to prevent permeation from inside to outside; it's for the other way around also.
- the substrate on which the native whey protein is deposited during the coating step can be of different material.
- the substrate on which the whey-protein could be coated is selected from paper, cardboard, metallic foil, or plastic. More preferably, the substrate is a plastic film, particularly a polymeric film selected from polyethylene terephtalate (PET) or polyolefins such as polypropylene (PP), polyethylene (PE).
- PET polyethylene terephtalate
- PP polypropylene
- PE polyethylene
- polyester polystyrene (PS), polyvinyl chloride, nylon, ethylene vinyl acetate and ethylene vinyl alcohol polymer, ethylene vinyl alcohol (EVOH), LDPE/LLDPE, polyvinylidene chloride (PVdC), polylactic acid (PLA), low density polyethylene (LDPE), ethylene vinyl acetate (EVA), crystallized polyethylene terephthalate (CPET), amorphous polyethylene terephthalate (APET), polyvinyl chloride (PVC), poly(butylene adipate-co-terephthalate), high density polyethylene (HDPE) and polyhydroxyalkonoates (PHA) such as polyhydroxybutyrate (PHB) could also be used as substrate materials.
- PS polystyrene
- PVdC polyvinylidene chloride
- PLA polylactic acid
- LDPE low density polyethylene
- EVA ethylene vinyl acetate
- CPET crystallized polyethylene terephthalate
- APET amorphous poly
- whey is a natural product, though it can come in various forms and from different origins. As a living feedstock, it also has some inherent variability, and storage conditions can also impact its properties. Protein products can vary in their properties over a wide range depending e.g. on raw material, processing, nativity or pureness. Thus, in the procedure of the present invention it is possible to use not only commercially available WPC and WPI products but also WPC and WPI obtained from sour whey or sweet whey.
- whey protein isolates can also be purified using ion exchange chromatography.
- the whey protein product suitable for the process of the present invention shows a high degree of pureness, a high dry mass content, high protein content, and high protein nativity degree.
- the degree of pureness of the whey protein (measured as the % protein content by dry matter (d.m.)) is preferably between 60-100 % d.m., more preferably 80-99% d.m. most preferably 85-99% d.m.
- the dry mass content for dried whey powders is usually in the range of 85 to 98 %.
- the whey protein fraction is subjected to minimal high temperature treatment (below 58 Q C for aqueous solutions, thus avoiding denaturation of the protein) during concentration of the whey which may include the steps of ultrafiltration, evaporation and spray drying.
- the term “denaturation” refers to thermal induced denaturation of the protein, wherein the native protein have undergone changes in its secondary or higher-order structure as a consequence of a heat treatment.
- the protein nativity degree of the coating solution should be maintained in the range between 40- 100%, preferably 65-100%, most preferably 75-100%.during the coating step.
- whey protein concentration is limited to 10% in denatured application whatever coating process is used. Owing to aggregation of the protein molecules during denaturation, due to disulphide and hydrogen bonds, the volume fraction increases which leads to higher viscosity. WPI concentrations above 10 % result in formation of a gel. On the contrary, in the process according the present invention, due to the fact that native proteins show lower viscosity it is possible to increase the dry matter content of whey protein solutions. Higher whey protein concentrations are also possible. Furthermore denaturation takes place directly in the dryer of the coating machine which has the advantage that one step in the process, denaturation before coating, is omitted. This is a big advantage regarding ecological (lower energy consumption) as well as economical aspects.
- the protein nativity was examined by differential scanning calorimetry using Q 2000 DSC (TA Instruments, New Castle Delaware, USA).
- Differential Scanning Calorimetry is a thermo analytical technique which measures the necessary energy to increase the temperature of a sample and a reference material as function of temperature. In this analysis the temperature increases linearly during the measurement (heating rate e.g. 10K/min).
- DSC analysis measures the amount of energy necessary for the unfolding of the protein, due to their denaturation (denaturation enthalpy). By that, endotheric and exothermic reactions (e.g. crystallisation, protein denaturation, starch gelling) in the tested samples can be analysed.
- aqueous protein solutions from the WPC or WPIs at pH 7 are prepared and subsequently analyzed. Therefore samples of the protein solutions (10 mg) were sealed into pans and heated from 23 to 120 °C in the DSC cell.
- the degree of denaturation is calculated taking as zero denaturation the highest measured denaturation enthalpy, that was measured for a commercially available whey protein isolate: BiPro from Davisco Foods Int., USA with a denaturation enthalpy of 8.2 J/g d.m. In 10% aqueous solutions denaturation peaks appear within the temperature range 65 to 80 °C.
- a similar method for measuring protein nativity of whey protein in the dried coating can be carried out in order to determine the nativity degree of the final product after drying step.
- denaturation temperatures are higher due to the absence of water.
- the degree of denaturation is calculated taking as zero denaturation the value of denaturation enthalpy of the dried sheet at 23 °C (internal standard).
- dissociated whey proteins act as plasticizer. Their ability to bind more water intensifies the plasticizing effect and allows reduction or even complete absence of a plasticizer in the whey proteins coating solution.
- the whey protein solution is mixed with plasticizers in order to improve the thermo-mechanical behaviour of the film.
- plasticizers are mandatory whenever considering a new material. Therefore, deformability and deformation speed rate need to match that of conventional materials at adequate temperatures.
- the plasticizers, making the film more flexible, will allow tuning the processability of the resulting material.
- plasticizers are defined as "substantially non-volatile, high boiling, non-separating substances, which when added to another material change the physical and/or mechanical properties of that material". Plasticizers reduce intermolecular forces like hydrogen bonding and allow better movement of the polymer chains.
- the presence of a plasticizer results in a reduction of brittleness and prevention of cracking.
- plasticizers already known in the art could be used.
- the plasticizer is selected from polyethylene glycol (PEG), propyleneglycol (PG), glycerol and sorbitol. Being particularly preferred the use of sorbitol or glycerol.
- the amount of plasticizer in the composition ranges from 20 - 200 wt. % based on the dry matter content of whey protein. Preferably, between 50-120 wt. %, and more preferably between 66-100 wt.%. Best results using sorbitol are obtained with an addition to the solution of 80- 120 wt.
- % based on the dry matter content of whey protein. More preferably, with an addition of 100 wt. % sorbitol. Whereas, using glycerol, best results are obtained adding between 50-80 wt. %, based on the dry matter content of whey protein, to the solution. Preferably, adding 67 wt. % glycerol.
- dry matter content or “solid content” refers to the sum of the protein concentration and the amount of plasticizer together with the content of other minor components such as lactose, mineral salts, etc.
- the coating composition has a dry matter content between 5-75 wt. %.
- the dry matter content is between 10-60 wt. %, more preferably 15-50 wt. %, being particularly preferred between 20-45 wt. %.
- the protein content in the coating solution to be applied onto the substrate is up to 40 % w/w, preferably up to 30% w/w, and more preferably up to 20% w/w.
- the amount of protein content in the coating solution depends on the plasticiser and the amount thereof.
- the preferred amount of protein concentration is between 15-25 % w/w, being particularly preferred a protein concentration of 20 % w/w in the coating solution, which results in obtaining coated films with similar mechanical properties than with lower concentration.
- the preferred amount of protein concentration is between 20-35 % w/w, being particularly preferred a protein concentration of 25 % w/w in the coating solution.
- the maximum whey protein concentration which could be properly used can be increased when native protein is used instead of denatured protein:
- the total dry matter content in native whey protein formulations can be significantly increased compared to denatured formulations. This is an important fact for industrial processing. Higher dry matter content results in shorter drying time. In addition curing of the proteins directly in the dryer saves an auxiliary processing step. Viscosities of native and denatured formulations strongly differ from each other. This influences the coating system that can be used for industrial application.
- the coating composition of step a) further comprises other additives selected from anti-oxidants, antimicrobials, colorants, pigments, ultraviolet absorbers, antistatic agents, crosslinkers, fillers, oxygens scavengers, humidity absorbers, biocides. and mixtures thereof.
- the main focus for the invention is the replacement of synthetic barrier layers, such as EVOH, by whey-protein in multilayer packaging applications while maintaining the high oxygen barrier, as well as other thermo-mechanical properties.
- synthetic barrier layers such as EVOH
- Modifications can be used to adapt the original protein properties to a desired functionality, for example to make film formation more homogenous, and therefore also to prevent the agglomeration and obtain a suitable film building behaviour. These modifications are applied with the proteins' native state maintained.
- the process further comprises to carry out a protein modification previously to its use in the coating step.
- the protein modification may be carried out by:
- Enzymatic hydrolysis is used if a reduction of molecular weight is of advantage and highest solubility is required.
- a severe heating step is required to inactivate the enzymes, therefore, in the case that an enzymatic hydrolysis is carried out, the heating step in order to inactivate the enzymes must be carried out after the coating step, i.e. during drying of the whey-protein coated substrate.
- Another possibility is, only to incorporate a small amount of enzymatic modified whey protein, so that the total share of native protein maintains above 40% of the total protein amount.
- the realized enzymatic hydrolysis is carried out with the enzyme Alcalase® 2.4 (Novozymes A/S, Bagsvaerd, Denmark), although other protease enzymes currently known in the art could be used.
- Physical modification with dynamic high pressure is a milder process leading to dissociation of protein aggregates and partial unfolding of the molecules.
- Physical modification e.g. high pressure homogenisation with pressure lower than 2000 bar
- High pressure homogenization can improve film building of partially denatured proteins to some extend, however it reduced somewhat agglomeration and may therefore contribute to improved properties or processability.
- Acetylation with acetic anhydride inserts covalent bound neutral acetyl groups to the protein amino group. This results in a partial unfolding of the protein backbone because of reduced electrostatic attraction between oppositely charged amino acid side chains. Practical effects of acetylation may involve a slight increase of aqueous solubility, reduced isoelectric point, and decreased tendency to gel upon heating.
- succinic anhydride introduces anionic succinate groups covalently linked to the amino groups of lysine.
- Succinylation generally has greater effects upon protein conformation and functional behavior than acetylation.
- Alterations of functionality commonly associated with succinylation include increased aqueous solubility, enhanced hydration, and modified surfactant properties. Because of that, enhanced building of homogenous films may be possible.
- the degree of modification is highly dependent on the added amount of anhydride. With an amount of 5 %, related to the protein mass, a degree of modification of about 55 % was reached for both acetylation and succinylation. A modification degree of about 94 % was achieved by applying 10 % anhydride. The addition of 20 % anhydride led to a degree of modification of approximately 97 %.
- Substrates with polar nature like PLA, EVOH, can be coated directly. Nevertheless surface of substrates with non-polar nature are not likely to offer binding sites for WPI coatings. Therefore, according to a preferred embodiment, in case of substrates with non-polar nature like PE, the whey- based formulation is coated on the surface of the substrate right after the substrate goes through a surface pre-treatment.
- the surface pre-treatment is a corona discharge treatment.
- Corona discharge, as well as other known surface activation treatments results in an improved wettability, compatibility and adhesion of the substrate.
- Corona discharge treatment is a form of plasma treatment: it operates at atmospheric pressure and it is necessary to decrease the surface energy of many plastics including polyolefin films. Decrease the surface energy means increases the wettability and the surface adhesion of the coating.
- This process is formed by different parts: - the film pass over a metal roller which is covered with an insulating material;
- a high frequency generator (10-20 kHz ) and step-up transformer which transfer a high voltage (typically 20 kV) to the electrode.
- the applied voltage ionizes the air and it becomes plasma. It consists in ions, electrons, excited neutrals and photons in the UV visible region.
- the current flow comes from the electrode directly to the polymer surface and the oxidation takes place developing the successive introduction of polar functional groups
- the corona treatment two reactions take place: the production of carbonyl and the production of ether.
- the first reaction takes place at a faster rate than the second reaction and it is the desired one.
- the increase of the energy surface is due to the formation, at the beginning of the reactions, of high polar groups such as carbonyl, carboxyl and hydroxyl.
- the second reaction is the conversion of these carbonyl groups into ether groups which are non polar groups and this tends to lower the surface energy.
- the substrate goes through a corona pretreatment in order to achieve sufficient adhesion of the whey coating to the substrate better than 1 .5 N/15mm, according to EN ISO 4624:2002.
- Solution preparation
- air bubbles can be formed in the solution. Therefore, according to an embodiment of the present invention, before using the solution for the coating process, the air bubbles should be removed to have a final homogeneous layer deposited of coating on the substrate, e.g. by putting the solution into an ultrasonic bath to break and remove all the air bubbles, or by mixing the components under vacuum.
- the process comprises additional steps other than mixing the whey-protein with the plasticizer and coating the mixture onto the substrate. Therefore, according to an embodiment of the present invention, processing properties of the whey protein products were in general improved with increasing protein pureness and maintained protein nativity. Decreasing mineral contents, in particular bivalent ions such as Ca 2+ , results in a reduced aggregation during heating of aqueous protein solution that enables the formation of smooth and fine stranded films. Further, pH values far from the isoelectric point improved film building properties. Influence of NaCI was independent of the nature of the whey protein. Either no salt or very small amounts of NaCI (up to 1 %, more preferably up to 0.5%) had a desirable effect.
- the process according to the present invention may comprise the following steps:
- additives selected from anti-oxidants, antimicrobials, colorants, pigments, ultraviolet absorbers, antistatic agents, crosslinkers, fillers, oxygens scavengers, humidity absorbers, biocides, or mixtures thereof;
- a pretreatment preferably corona treatment, in order to have a good adhesion and compatibility between the whey-protein layer and the substrate, and to increase the wet ability of the substrate;
- composition resulting onto the substrate film maintaining at least 40% of the whey protein isolate or concentrate in their native state
- a packaging material including at least one or more layers of the whey-protein coated substrate film that is obtained by the method of the present invention, the packaging material being laminated with another material, is also one of preferred embodiments of the present invention.
- this packaging material can be selected freely as needed, a representative example may include providing a sealant layer for thermal adhesion or thermosealibility in the outermost layer and also combining with a polyolefin film, a polyester film, or the like according to the intended use.
- Whey protein layer properties The boundaries in oxygen barrier properties are difficult to define, especially because each market requires different levels of oxygen and humidity barriers.
- the film thickness can also be varied in order to compensate different intrinsic barrier efficiency.
- the samples for the measurements of the Oxygen Transmission Rate (OTR) and the Water Vapour Transmission Rate (WVTR) are prepared in pieces of 20 x 20 cm and after inserted into the device for the analysis.
- the sample works like a membrane between two different atmosphere: in both kinds of analysis the coated side is placed in the upper part of the chamber (pure oxygen for the OTR and high level humidity for the WVTR) to simulate the nearest condition to the reality.
- the coated side of the sheet is in the part where the pure oxygen passes and for the WVTR on the side of 85 % RH.
- the oxygen is humidified to 50% before entering into the chamber and the carrier gas is purified with the use of a catalyst.
- the reference measurement (zero) is made by fluxing pure nitrogen in the upper side of the chamber to have the same kind of flux and substance in the upper and in the lower half of the cell.
- the film acts as a membrane and the transfer of the oxygen is due to the difference in partial pressure of it: the gas moves by diffusion into the film until the time that the driving force is equals constant and an equilibrium state is reached.
- the rate of oxygen is measured with a detector in the outgoing stream of the dry side and this is the value of the oxygen transmission rate to take in consideration. The final result is given in cm 3 /m 2 d bar.
- Oxygen and water vapour permeability values of whey-based coatings are converted to a thickness of 100 ⁇ (Q-ioo) in order to allow direct comparison of different materials independently of the coating thickness.
- Film thicknesses were measured with the instrument Mahr Millimar C121 6 of Mahr GmbH (Gottingen) after oxygen transmission tests. WPI coating thickness was calculated by subtracting the base for substrate film.
- This trial permits to determine the WVTR: it measured the amount of water vapour passing trough the sample during a period of time in specific condition of temperature and gradient of relative humidity (23 Q C and 85 ⁇ 0% of relative humidity).
- the apparatus for the measurement of the WVTR is similar to the one for the OTR: here the dry nitrogen (carrier gas) sweeps the lower half of the chamber, in the upper side it is placed a porous frit soaked with a mixture of sulphuric acid and water.
- the RH (equals to 85%) is established on the ratio between the concentration of the acid and amount of water.
- the nitrogen (carrier gas) is dried to 0% of RH before entering into the lower half part of the chamber by a desiccant. It takes the humidity permeated trough the sample and carries it to the sensor to trace the necessary current required for the electrolytic decomposition of the water. In this case the result is indicated as g/m 2 d.
- thermo-mechanical properties the whey-protein coated substrate film obtainable by the process of the invention shows suitable thermo-mechanical properties, which are prerequisites for processability, and also shows suitable capability to withstand post operations and suitable use and durability.
- the whey-protein coated substrate film obtainable by the process of the invention is capable of withstanding a substantial deformation (locally up to 400%) without crack initiation during the process at temperatures varying depending on the substrate. Additionally, thermal properties are also important because of filling conditions (e.g. hot filling possibility), post- packaging operations (possibly sterilisation, pasteurisation, microwaving of packed food etc.) and storage conditions (for freeze packed food). Adequate mechanical strength throughout the service life is necessary to ensure the integrity of the packaging.
- the mechanical properties of the whey-protein coated film on a PET film ranges as follows:
- the whey-protein coated film obtainable according to the process of the present invention shows suitable additional features such as those qualifying the aspect of the layer, scratch resistance, gloss, transparency, and surface finish after mechanical stress.
- the bond strength measurement method measures the interlaminar strength which keeps together two different surfaces and was applied to the laminate samples (e.g. PET/Whey-protein layer/Adhesive/PE).
- the equipment is composed by the same machine and clamps used as for the commonly used tensile and the tear test (sample holder according to EN ISO 4624 and EN ISO 527-1 ).
- sample holder according to EN ISO 4624 and EN ISO 527-1 .
- two samples with dimensions 100 mm per 15 mm are prepared and they are cut according to either the machine or the transverse direction.
- the two surfaces are then split up for a length of 40 mm and kept in constant conditions of 23 Q C and 50 % relative humidity.
- the ends of the samples are positioned into the clamps of the tensile machine and the bond strength is measured.
- the adhesion between the whey layer and the substrate is measured according to the International Standard EN ISO 4624:2002 (pull-off test).
- the coating process may be carried out by different coating technologies known in the prior art.
- the coated film may go through the coating process various times for example to apply the whey-based surface layer after lamination of the whey- based barrier layer with the second structural layer, or by making successive coatings to increase the thickness of the barrier layer.
- the proteins are heated above their glass transition temperature to form a film, whereas in the latter, the protein dispersion is applied to form a film (by spray, brush, coater, etc.).
- the coating process is carried out by a lacquering process.
- the coating solution comprising water, whey protein and plasticizers
- a stainless steel roll or of different suitable material
- the different techniques of coating depend on the viscosity of the solution that must be deposited. If the solution is not very viscous, like emulsions, it is better to use air knifes, blades or bar coaters.
- roller coating process is preferable since it offers the most promising method for the industrialization purpose whereby the whey suspension is to be applied on the plastic substrates.
- the reverse gravure coating system is based on an engraved roller immersed in a tank, where the coating material fills the roller engravings or slits.
- the coating is deposited on the substrate as it passes between the engraved roller and the pressure roller while excess material is removed by the doctor blade.
- the coating material is measured onto the application roller thanks to precision setting of the gap between the metering roller lying above the application roller.
- the coating material is brushed off the application roller by the substrate as it passes around the bottom support roller.
- Roller application Coating material is 1 -10000 mPas taken up from an
- Gravure coating Coating material is 1 - 15 000 mPas taken up from an
- Comma rod Coating material is 100-50000 mPas applied to the substrate
- Air knife Coating material is 5 - 10000 mPas applied to the substrate
- Spray coating Liquid is atomized into 50 - 150 mPas
- the native formulation can be applied at lower shear rate, preferably the method include via roller, airknife, curtain and slot coating.
- Films coated according the process of the present invention with native whey proteins show the same good mechanical properties as those coated with denatured proteins. However, scratch resistance is rather low which allows reduction of the plasticizer to approximately half of the denatured reference formulation, and is not a problem when the coating is used as an interim layer. Additionally further crosslinking of the proteins takes place over time which strengthens the network.
- the whey-protein coated substrate film is dried and cured by heat treatment. Partial denaturation of the proteins occurs in this final step of the process.
- the method of drying the coating liquid layer is not particularly limited, for example a hot roll contact technique, a heat medium (air, oil, and the like) contact technique, an infrared heating technique, a microwave heating technique, an ultraviolet heating technique, and the like. It is possible to use two or more than these drying methods simultaneously or at staggered times to improve drying efficiency but also protein denaturation and crosslinking.
- the hot gas comes in contact with the product.
- they are included the drying tunnel and the spray drying.
- a flow of hot air is used to move away the water from the product.
- unwinding zones can be used for its transport through the tunnel, or for example, if the material has the shape of slices a belt conveyor can be employed.
- Indirect dryers in these the heat, from hot gas, steam or thermal fluids, doesn't enter in contact with the product that has to be dried.
- the heat from the hot fluid to the material is transferred by conduction through a surface.
- rotary, cone, drum and tray dryer In this class are included rotary, cone, drum and tray dryer.
- the drying step is carried out in a drying tunnel.
- the drying tunnel may operate having an almost constant drying temperature or, alternatively, it is possible to design the drying tunnel in such a way that a variable cycle of temperature is applied along the tunnel.
- the drying tunnel may operate with different heating techniques simultaneously or sequentially as previously listed.
- the drying temperature to be applied ranges from 60 Q C to 1 60 Q C, preferably from 100 °-C to 140 °-C
- the denaturalization degree which can be achieved during the drying step not only depends of the heating method and the temperature, but also on the drying time which is depending on the dryer length and the coating speed.
- the whey protein layer is able to serve as good oxygen barrier and can either serve as upper layer or as sandwich layer in a composite. After a lamination stage, it is possible to obtain proper composites with whey protein coated polymer films. Depending on the position the whey layer holds (upper layer or sandwich layer) it meets different demands. Besides this fact a suitable formulation can be chosen according to factors like packed good, product shelf life or consumer demands.
- the whey-protein coated film may undergoes post processes in order to be formed into packaging by e.g. thermosealing or thermoforming, and is then filled with the food before optionally going through post-packaging operations such as pasteurisation.
- the whey-protein coated substrate film obtainable by the process of the present invention is compatible with specific post process temperatures and parameters for thermo-sealing, thermoforming and post-packaging operations such as pasteurization, sterilization, vacuum packaging: no cracking, and no alteration of properties at long term.
- the whey-protein based coated substrate improves barrier properties of the substrate it is applied on: lower than 20 cm 3 /m 2 d bar for oxygen (23 °C, 50% rH) and lower than 50 g/m 2 d for water vapour permeation (23 °C, 85% to 0% rH) for protein on polymer film substrate like PET.
- OTR and WVTR values are related to Qioo values, i.e. normalized to a 100 ⁇ thickness.
- a thickness of the coating composition when laminated with the substrate is not particularly limited, it is preferably from 5 to 50 ⁇ , more preferably between 7-20 ⁇ . Greater thickness can be achieved by applying and drying several successive coating layers.
- Example 1 Preparation of the coating formulation. Preparation of native coating formulations and pre-denatured coating formulation (comparative) was carried out as follows.
- Whey protein isolate (WPI) BiPro of Davisco Foods International (Le Sueur) (dry protein pureness 97.4 %; N x 6.38) was used for formulating the whey- based coatings in the present study.
- Glycerol and sorbitol used as plasticizer were supplied by Merck Schuchard OHG (Hohenbrunn) and Merck KGkA (Darmstadt) respectively.
- Preliminary trials showed that solutions with 12 wt. % whey protein isolate are gelatinizing during denaturation process (critical concentration at 12 wt. % was observed). For that reason further formulations were prepared using 10 wt. % WPI-solutions because they were easier to handle.
- Pre-denatured protein formulations were prepared by heating aqueous WPI solutions (10 % w/w of the total mass of the solution) to 90 °C for 30 min (above their temperature of denaturation of around 58-60 Q C as measured by DSC) using an electronic stirrer with heating, Thermomix 31 -1 , from Vorwerk Elektrowerk GmbH & CoKG (Wuppertal). After cooling the solutions to room temperature in a water bath, 10 wt.
- % of sorbitol 50 wt. % of the amount of dry matter based on the dry matter content of whey protein was added and stirred for another 30 min (at 200 rpm). Degassing was performed via ultrasonication in each stage.
- viscosity of the whey protein solution was a limiting factor of coating process, for comparison reasons 10 wt. % denatured whey protein and 20 wt. % native whey protein were used due to they show similar viscosity profile.
- the amount of plasticizer is given as percentage and is always referred to the total amount of protein in the solution.
- the machine used for the coating of the film and drying in a hot air continuous tunnel dryer was a customized Floatec / Rolltec-Highdry 250 model from Drytec, Hamburg-Nordstedt, Germany.
- the main parts of the machine are in order:
- the film after the lacquering step (and corona pre-treatment, 200 W) was entered into the machine and move progressively through the tunnel in contact with hot air.
- a gravure roll was used for the coating operation.
- the hot air come only from the down side to heat the substrate and to remove the dirty particles and the air entrapped contained into the whey solution.
- the air flow comes from both sides of the machine and the drying of the whey layer starts from the upside too.
- the hot air comes out from nozzles arranged all along the length of the machine to have a constant flow on the entire drying surface and to maintain constant the operation temperature too.
- the dryer provides 8000 m 3 / h of air and 1 /4 of this volume was re-circulated.
- the length of the drying tunnel was 4.2 m and the speed of the rolls which pull the substrate was 3 m/ min, this means that the drying time was 1 .4 minutes in this example. Depending on the drying conditions (e.g. air velocity) the drying can be performed faster.
- the resulting dry coating thickness ranges between 5 and 6 ⁇ .
- the aim of this example was to obtain good barrier properties against oxygen and water vapour comparable to those obtained by using material such as Ethylene vinyl alcohol (EVOH) as barrier layer.
- EVOH Ethylene vinyl alcohol
- Two different laminated were produced: one using a coating solution of native whey proteins and the other using a coating solution of fully denatured whey proteins (solutions obtained as described in example 1 ).
- the first laminate was so formed using native whey protein solution:
- the PET was coated with native whey protein solution and dried at 140 Q C, to obtain a significant denaturation of the proteins.
- the adhesive solution was deposited on the PE always with the use of a gravure roll and then dried at a temperature of 60 Q C.
- This adhesive solution was composed of:
- the Liofol (300 g) was initially mixed with Ethyl acetate (434 g) and later the Harter (6 g) was added at the solution. It must be considered that 1 kg of solution Liofol / Harter and 1 .42 kg of solvent give a final solution with 30 wt. % of dry matter content.
- the coated PET and the coated PE were put inside the lacquering machine and laminated with use of two cylinders which turn in opposite direction (the lamination zone is arranged in the last part of the machine, near the unwinding unit).
- the samples for the measurements of the OTR and the WVTR were prepared in pieces of 20 x 20 cm and after inserted into the device for the analysis as described in the barrier properties measurement description.
- the degree of denaturation is calculated taking as zero denaturation the value of denaturation enthalpy of the sheet dried at 23 Q C: Den. ⁇
- Den x and Den 2 3 are respectively the value of the denaturation enthalpy at the general x drying temperature and 23 Q C.
- OTR was measured according to DIN 53380-3 (DIN, 1998) with an instrument of Brugger Feinmechanik GmbH which was located in an air-conditioned laboratory at 23 °C.
- the coated film was placed between two measuring cells. After rinsing the two chambers with nitrogen to determine the reference value (in case of any leakage), a stream of oxygen was passed through the first chamber whereas the other chamber was purged with nitrogen as carrier gas. To guarantee that only pure nitrogen passes through the second chamber nitrogen and 2 % of hydrogen was induced.
- At the catalyst hydrogen reacts in case of presence of oxygen and forms water.
- For creating RH of 50 % carrier gas and oxygen was passed through humidifiers. Over time oxygen passes the film and is dissolved in the carrier gas which passes a detector.
- the electrochemical detector enables oxygen molecules to react at the graphite- cathode and the cadmium-anode (saturated in caustic potash) and to generate electrical current that is proportional to the amount of oxygen.
- the degree of denaturation is calculated taking as zero denaturation the value of denaturation enthalpy of the dried sheet at 23 °C (internal standard).
- the higher nativity of the proteins used can be confirmed considering the respective denaturation enthalpy which decreases by applying higher drying temperatures. It is possible to achieve similar OTR and WVTR values compared with pre-denatured protein formulations.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Plasma & Fusion (AREA)
- Laminated Bodies (AREA)
- General Preparation And Processing Of Foods (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Coating Of Shaped Articles Made Of Macromolecular Substances (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT117648576T PT2734575T (en) | 2011-07-22 | 2011-07-22 | FILMS COATED WITH MILK SERUM PROTEIN |
| SM20200087T SMT202000087T1 (en) | 2011-07-22 | 2011-07-22 | Whey protein coated films |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2011/053271 WO2013014493A1 (en) | 2011-07-22 | 2011-07-22 | Whey protein coated films |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2734575A1 true EP2734575A1 (en) | 2014-05-28 |
| EP2734575B1 EP2734575B1 (en) | 2019-09-04 |
Family
ID=44759730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP11764857.6A Active EP2734575B1 (en) | 2011-07-22 | 2011-07-22 | Whey protein coated films |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20150225152A1 (en) |
| EP (1) | EP2734575B1 (en) |
| JP (1) | JP6117782B2 (en) |
| AU (1) | AU2011373908B2 (en) |
| ES (1) | ES2777941T3 (en) |
| PT (1) | PT2734575T (en) |
| SM (1) | SMT202000087T1 (en) |
| WO (1) | WO2013014493A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3241677A1 (en) | 2016-05-03 | 2017-11-08 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Thermoformable multi-layer composite with oxygen barrier and protein-containing formulation for producing the multi-layer composite |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE538081C2 (en) * | 2013-07-16 | 2016-03-01 | Tetra Laval Holdings & Finance | Packaging laminate and packaging container for a liquid fermented milk product |
| BE1023737B1 (en) * | 2013-09-13 | 2017-07-06 | Resilux | METHOD FOR MANUFACTURING A COATED FORM AND CONTAINER |
| US10968260B2 (en) * | 2014-05-12 | 2021-04-06 | Haus Bioceuticals, Inc. | Curcumin-peptide conjugates and formulations thereof |
| DE102017202887B4 (en) | 2017-02-22 | 2024-05-29 | Uwe Vorreiter | Coating solution for coating a packaging material to produce a barrier layer, a process for its production and its use |
| KR102138877B1 (en) * | 2018-09-20 | 2020-07-29 | (주)에버켐텍 | Uv blocking film for food packaging and method for manufacturing same |
| DE102019110593A1 (en) | 2019-04-24 | 2020-10-29 | PAPACKS SALES GmbH | Barrier layer for cellulose substrate |
| TR202007641A2 (en) * | 2020-05-15 | 2021-11-22 | Istanbul Teknik Ueniversitesi Bilimsel Ararstirma Proje Birim | PRODUCTION OF BIOPLASTIC BY FRACTION OF CHEESE Whey COMPONENTS AND METHOD OF PRODUCTION OF BIODEGRADABLE/BIOCOMPATIBLE MEMBRANES |
| BR112023002848A2 (en) * | 2020-08-28 | 2023-03-14 | Nestle Sa | PACKAGED FOOD CONCENTRATE WITH BARRIER PROPERTIES PROVIDED BY AN EDIBLE PACKAGING |
| CN112321877B (en) * | 2020-11-05 | 2023-04-07 | 中红普林医疗用品股份有限公司 | Preparation method of food packaging film with waterproof vapor permeability |
| FR3141949B1 (en) * | 2022-11-16 | 2024-10-25 | Guyenne Papier | Process for manufacturing a flexible support coated with a heat-sealing film-forming polymer |
| CN117101431A (en) * | 2023-09-22 | 2023-11-24 | 哈尔滨工业大学 | An activated atomic layer deposition super-hydrophilic polymer separation membrane and its preparation method |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD240831A1 (en) * | 1985-09-11 | 1986-11-19 | Adw Ddr | PROCESS FOR OBTAINING CHEMICALLY MODIFIED PROTEINS |
| SE459140B (en) * | 1986-11-25 | 1989-06-12 | Albuglobe Ab | HYDROLYSIS OF WHEAT PROTEIN TO PROVIDE SEPARATE SEPARATION OF FAT |
| US5543164A (en) * | 1994-06-17 | 1996-08-06 | The Regents Of The University Of California | Water-insoluble protein-based edible barrier coatings and films |
| EP0995781B1 (en) * | 1998-04-23 | 2004-08-18 | Idemitsu Petrochemical Co., Ltd. | Coating material |
| US6441117B1 (en) * | 1999-09-01 | 2002-08-27 | E. I. Du Pont De Nemours And Company | High density polyethylene packaging |
| GB0027876D0 (en) * | 2000-11-15 | 2000-12-27 | Ucb Sa | Coated films and coating compositions |
| EP1679975A1 (en) * | 2003-10-15 | 2006-07-19 | Uniq Bioresearch Oy | Method for strengthening a protein-containing product and a protein-containing product |
| JP4601393B2 (en) * | 2004-10-29 | 2010-12-22 | 日本テトラパック株式会社 | Packaging materials |
| DE102006027493A1 (en) * | 2006-02-15 | 2007-08-23 | Kalle Gmbh | Food casing with a make coat containing transferable additives |
| EP1860138A1 (en) * | 2006-05-25 | 2007-11-28 | Sabanci Universitesi | Biodegradable thermoplastic nanocomposite polymers |
| EP2247659B1 (en) * | 2008-02-01 | 2017-03-22 | L'Oréal | Biodegradable moisture-impermeable packages for consumer goods |
| CN103005464B (en) * | 2008-10-17 | 2015-01-07 | 雀巢产品技术援助有限公司 | Whey protein compositions, methods and uses |
| IT1396554B1 (en) * | 2009-02-03 | 2012-12-14 | Metalvuoto S P A | NATURAL MACROMOLECULAR LACQUER WITH BARRIER EFFECT MODULATED IN SITU GAS AND RELATED PREPARATION METHODS |
| US20110135912A1 (en) * | 2009-06-16 | 2011-06-09 | Meadwestvaco Corporation | Biodegradable packaging materials with enhanced oxygen barrier performance |
-
2011
- 2011-07-22 EP EP11764857.6A patent/EP2734575B1/en active Active
- 2011-07-22 WO PCT/IB2011/053271 patent/WO2013014493A1/en not_active Ceased
- 2011-07-22 SM SM20200087T patent/SMT202000087T1/en unknown
- 2011-07-22 US US14/234,296 patent/US20150225152A1/en not_active Abandoned
- 2011-07-22 AU AU2011373908A patent/AU2011373908B2/en not_active Ceased
- 2011-07-22 ES ES11764857T patent/ES2777941T3/en active Active
- 2011-07-22 JP JP2014520741A patent/JP6117782B2/en not_active Expired - Fee Related
- 2011-07-22 PT PT117648576T patent/PT2734575T/en unknown
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2013014493A1 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3241677A1 (en) | 2016-05-03 | 2017-11-08 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Thermoformable multi-layer composite with oxygen barrier and protein-containing formulation for producing the multi-layer composite |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2777941T3 (en) | 2020-08-06 |
| PT2734575T (en) | 2019-12-30 |
| US20150225152A1 (en) | 2015-08-13 |
| AU2011373908B2 (en) | 2015-11-12 |
| AU2011373908A8 (en) | 2014-04-03 |
| EP2734575B1 (en) | 2019-09-04 |
| JP6117782B2 (en) | 2017-04-19 |
| SMT202000087T1 (en) | 2020-05-08 |
| AU2011373908A1 (en) | 2014-03-13 |
| JP2014521498A (en) | 2014-08-28 |
| WO2013014493A1 (en) | 2013-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011373908B2 (en) | Whey protein coated films | |
| Gällstedt et al. | Packaging‐related properties of protein‐and chitosan‐coated paper | |
| EP3517291B1 (en) | Barrier film and laminated packaging material comprising the film and packaging container made therefrom | |
| Hong et al. | Oxygen barrier properties of whey protein isolate coatings on polypropylene films | |
| JP2018533525A (en) | Laminated packaging material comprising barrier film or sheet and film or sheet thereof and packaging container made therefrom | |
| CA2672779A1 (en) | Biaxially stretched polyamide resin film and production method thereof | |
| CN110944918A (en) | Packaging bags using polybutylene terephthalate film | |
| CN111511542B (en) | Barrier film, laminated packaging material comprising the film and packaging container made thereof | |
| Joo et al. | Whey protein-coated high oxygen barrier multilayer films using surface pretreated PET substrate | |
| JP6643829B2 (en) | Adhesives for packaging materials and packaging materials | |
| JP2025156554A (en) | Laminated film and standing pouches | |
| CN103987895A (en) | Methods to form an ionomer coating on a substrate | |
| AU2003262243B2 (en) | Inorganic layered compound dispersion, process for producing the same, and use thereof | |
| EP4477414A1 (en) | Biodegradable laminated body, method for producing same, and molded body | |
| WO2015112377A1 (en) | Alkali metal-magnesium ionomer compositions | |
| AU2023273187A1 (en) | Barrier-coated substrate, laminated packaging material and packaging container comprising the substrate | |
| US20240017534A1 (en) | Barrier-coated cellulose-based substrate, laminated packaging material and packaging container comprising the cellulose-based substrate | |
| US20150203615A1 (en) | Alkali metal-zinc ionomer compositions | |
| Doğan Atik et al. | Water vapour barrier performance of corn-zein coated polypropylene (PP) packaging films | |
| JP7788288B2 (en) | Biodegradable film and biodegradable laminate | |
| EP3368301A1 (en) | Barrier film or sheet and laminated packaging material comprising the film or sheet and packaging container made therefrom | |
| EP1161483A1 (en) | Process for producing a plastic web for coating a metal substrate, laminate comprising this plastic web, and product or component produced therewith | |
| US20220412009A1 (en) | Cellulosic laminar element, method for obtaining said element and receptacle made using said cellulosic laminar element | |
| Gerna | INTEGRATED GREEN STRATEGIES FOR THE MANAGEMENT, RECOVERY AND RECYCLING OF EXPIRED MILK. | |
| Schmid | Whey protein-based coatings as sustainable barrier material in food packaging applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20140220 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20170503 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20190325 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1175266 Country of ref document: AT Kind code of ref document: T Effective date: 20190915 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011061795 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Ref document number: 2734575 Country of ref document: PT Date of ref document: 20191230 Kind code of ref document: T Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20191217 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20190904 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191204 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191204 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1175266 Country of ref document: AT Kind code of ref document: T Effective date: 20190904 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200224 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602011061795 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG2D | Information on lapse in contracting state deleted |
Ref country code: IS |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200105 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2777941 Country of ref document: ES Kind code of ref document: T3 Effective date: 20200806 |
|
| 26N | No opposition filed |
Effective date: 20200605 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200731 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200731 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200731 Ref country code: SM Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210304 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200722 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200731 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20220131 Year of fee payment: 11 Ref country code: GB Payment date: 20220128 Year of fee payment: 11 Ref country code: DE Payment date: 20220128 Year of fee payment: 11 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20220121 Year of fee payment: 11 Ref country code: IT Payment date: 20220128 Year of fee payment: 11 Ref country code: FR Payment date: 20220128 Year of fee payment: 11 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190904 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20220729 Year of fee payment: 11 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602011061795 Country of ref document: DE |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20220722 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230123 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220731 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220722 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230201 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220722 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220722 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20230901 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220723 |